MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program
MagicMed Industries Inc. (CSE: MGIC reserved) (" MagicMed" or the " Company") announced today that it has completed the establishment of the psilocybin-derivatives patent portfolio of the Psybrary TM and the launch of the Candidate Selection program. The Psybrary TM is a proprietary physical and knowledgebase collection of novel psychedelic-derivative drug candidates, manufacturing methods, pharmacological data, and patent filings that protect all of the above. MagicMeds Chief Scientific O...
Peter Facchini Joseph Tucker Trademark Office Magicmed Industries Magicmed Industries Inc Med Industries
Source: prnewswire.com